Sex: F
Vaccine: COVID19
Symptoms: Blood pressure measurement, Gait disturbance, Headache, Hypertension, Vaccination site discharge
Clinical narrative: Her blood pressure was exacerbated/her blood pressure exacerbated to 200/116 or 200/120; Removed the bandage she noticed a silver metallic discharge on the band aid; Tremendous headaches; had difficulty walking on some days when she had the headaches; This is a spontaneous report received from a contactable reporter(s) (Other HCP) from medical information team. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 01), for COVID-19 immunization. The following information was reported: HYPERTENSION (medically significant) with onset 2021, outcome "unknown", described as "Her blood pressure was exacerbated/her blood pressure exacerbated to 200/116 or 200/120"; VACCINATION SITE DISCHARGE (non-serious) with onset 2021, outcome "unknown", described as "Removed the bandage she noticed a silver metallic discharge on the band aid"; HEADACHE (non-serious) with onset 2021, outcome "unknown", described as "Tremendous headaches"; GAIT DISTURBANCE (non-serious) with onset 2021, outcome "unknown", described as "had difficulty walking on some days when she had the headaches". The patient underwent the following laboratory tests and procedures: blood pressure measurement: 200/116 or 200/120. Therapeutic measures were taken as a result of hypertension. Clinical course: The patient got her vaccine in Apr or May second dose. Stated that when she removed bandage instead of drop of blood there was silver metallic discharge on the bandaid. Stated that since then she had tremendous headaches. Stated that shortly after her blood pressure exacerbated to 200/116 or 200/120 even after taking her blood pressure medicine. Stated that she has not been to a doctor. She was a nurse. Was concerned about the metallic substance on the bandaid, extreme headaches, blood pressure and it being difficult to really walk on somedays when she had headaches. Patient was scheduled for a MRI on Friday. Wanted to know what was the metallic substance. Stated that she has not gotten the booster and does not want the side effects getting worst. Stated that she has a lot of questions.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.; Sender's Comments: Based on temporal relationship the possibility of causal association between the reported events Hypertension, vaccination site discharge, headache, gait disturbance and the suspect drug BNT162B2 cannot be excluded.   The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.